From the standpoint of Lyme disease vaccines, LA-2 is highly significant as LA-2 equivalents, based on competitive ELISAs, correlate with protection from B. burgdorferi challenge in animal models ( 49 , 50 ).
← all excerpts
OspA antibodies inhibit the <i>in vitro</i> transmigration of <i>Borrelia burgdorferi</i>.
1
—
—